| Abiraterone and increased survival in metastatic prostate cancer JS De Bono, CJ Logothetis, A Molina, K Fizazi, S North, L Chu, KN Chi, ... New England Journal of Medicine 364 (21), 1995-2005, 2011 | 3995 | 2011 |
| β-Arrestin acts as a clathrin adaptor in endocytosis of the β 2-adrenergic receptor OB Goodman, JG Krupnick, F Santini, VV Gurevich, RB Penn, ... nature 383 (6599), 447-450, 1996 | 1516 | 1996 |
| Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo … K Fizazi, HI Scher, A Molina, CJ Logothetis, KN Chi, RJ Jones, ... The lancet oncology 13 (10), 983-992, 2012 | 1261 | 2012 |
| Arrestin/clathrin interaction: Localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus JG Krupnick, OB Goodman Jr, JH Keen, JL Benovic Journal of Biological Chemistry 272 (23), 15011-15016, 1997 | 306 | 1997 |
| Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant … CJ Logothetis, E Basch, A Molina, K Fizazi, SA North, KN Chi, RJ Jones, ... The lancet oncology 13 (12), 1210-1217, 2012 | 285 | 2012 |
| Arrestin/clathrin interaction: localization of the arrestin binding locus to the clathrin terminal domain OB Goodman Jr, JG Krupnick, VV Gurevich, JL Benovic, JH Keen Journal of Biological Chemistry 272 (23), 15017-15022, 1997 | 250 | 1997 |
| Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with … JC Gonzales, LM Fink, OB Goodman Jr, JT Symanowski, NJ Vogelzang, ... Clinical genitourinary cancer 9 (1), 39-45, 2011 | 138 | 2011 |
| Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors OB Goodman, LM Fink, JT Symanowski, B Wong, B Grobaski, ... Cancer Epidemiology and Prevention Biomarkers 18 (6), 1904-1913, 2009 | 122 | 2009 |
| Mapping of the molecular determinants involved in the interaction between eps15 and AP-2 G Iannolo, AE Salcini, I Gaidarov, OB Goodman, J Baulida, G Carpenter, ... Cancer Research 57 (2), 240-245, 1997 | 108 | 1997 |
| Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer OB Goodman Jr, JT Symanowski, A Loudyi, LM Fink, DC Ward, ... Clinical genitourinary cancer 9 (1), 31-38, 2011 | 100 | 2011 |
| Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer OB Goodman, TW Flaig, A Molina, PFA Mulders, K Fizazi, H Suttmann, ... Prostate cancer and prostatic diseases 17 (1), 34-39, 2014 | 86 | 2014 |
| A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors JS Weber, NJ Vogelzang, MS Ernstoff, OB Goodman, LD Cranmer, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 34 (7), 556, 2011 | 85 | 2011 |
| Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells J Gong, J Zhu, OB Goodman, RG Pestell, PN Schlegel, DM Nanus, ... Oncogene 25 (14), 2011-2021, 2006 | 79 | 2006 |
| Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy R Mitra, O Chao, Y Urasaki, OB Goodman, TT Le BMC cancer 12 (1), 1-9, 2012 | 69 | 2012 |
| Role of arrestins in G-protein-coupled receptor endocytosis OB Goodman Jr, JG Krupnick, F Santini, VV Gurevich, RB Penn, ... Advances in pharmacology 42, 429-433, 1997 | 65 | 1997 |
| Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase R Zheng, A Iwase, R Shen, OB Goodman, N Sugimoto, Y Takuwa, ... Oncogene 25 (44), 5942-5952, 2006 | 63 | 2006 |
| Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer JD Khoury, DM Adcock, F Chan, JT Symanowski, S Tiefenbacher, ... American journal of clinical pathology 134 (6), 964-969, 2010 | 60 | 2010 |
| The α chain of the AP-2 adaptor is a clathrin binding subunit OB Goodman Jr, JH Keen Journal of Biological Chemistry 270 (40), 23768-23773, 1995 | 58 | 1995 |
| Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP OS Chao, OB Goodman Molecular cancer research 12 (12), 1755-1766, 2014 | 56 | 2014 |
| Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2 OB Goodman Jr, M Febbraio, R Simantov, R Zheng, R Shen, ... Journal of Biological Chemistry 281 (44), 33597-33605, 2006 | 45 | 2006 |
Arturo Molina, MD, MS, FACPChief Medical Officer, Sutro BiopharmaVerified email at sutrobio.com
